REQUEST A DEMO
Total
USD $0.00
Search more companies

CKH Food & Health Limited (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: CKH Food & Health Limited Profile Updated: May 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

China King-Highway Holdings Limited engages in health food and supplements manufacturing and distribution. The company's product line up includes blood sugar supplements, growth promoters, diabetic prevention pills, immune boosters, and menopause supplements in the form of capsules, liquid, and tea bags. China King was established in February 2009 and listed in Korean Stock Exchange (KOSDAQ) on March 2010. The company's business location is in Fuzhou City China.

Headquarters
Ky1-1112, Grand Cayman
Cayman Islands;

Contact Details: Purchase the CKH Food & Health Limited report to view the information.

Basic Information
Total Employees:
Purchase the CKH Food & Health Limited report to view the information.
Outstanding Shares:
Purchase the CKH Food & Health Limited report to view the information.
Financial Auditors:
Purchase the CKH Food & Health Limited report to view the information.
Incorporation Date:
February 24, 2009
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
56.13%
Subsidiaries
복건영생활력생물공정유한공사 (China)
Company Performance
Financial values in the chart are available after CKH Food & Health Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-30.85%
Total operating revenue
-30.66%
Operating profit (EBIT)
11.03%
EBITDA
2.17%
Net Profit (Loss) for the Period
23.2%
Total assets
3.5%
Total equity
4.84%
Operating Profit Margin (ROS)
3.82%
Net Profit Margin
4.61%
Return on Equity (ROE)
0.26%
Debt to Equity Ratio
0.22%
Quick Ratio
31.94%
Cash Ratio
26.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?